Component: (Network and Table)
Network
00100 - Statement - Consolidated Balance Sheets
(http://www.t2biosystems.com.com/role/StatementConsolidatedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001492674 (http://www.sec.gov/CIK)
Consolidated Balance SheetsPeriod [Axis]
2016-12-31
2015-12-31
Consolidated Balance Sheets
 
 
Assets
 
 
Current assets:
 
 
Cash and cash equivalents
73,488,000  
73,662,000  
Accounts receivable
327,000  
369,000  
Prepaid expenses and other current assets
820,000  
838,000  
Inventories, net
803,000  
683,000  
Total current assets
75,438,000  
 
75,552,000  
 
Property and equipment, net
13,589,000  
10,655,000  
Restricted cash
260,000  
260,000  
Other assets
281,000  
358,000  
Total assets
89,568,000  
 
86,825,000  
 
Liabilities and stockholders' equity
 
 
Current liabilities:
 
 
Accounts payable
962,000  
1,228,000  
Accrued expenses and other current liabilities
4,908,000  
4,162,000  
Current portion of notes payable
1,269,000  
4,449,000  
Deferred revenue
2,445,000  
2,146,000  
Current portion of lease incentives
301,000  
268,000  
Total current liabilities
9,885,000  
 
12,253,000  
 
Notes payable, net of current portion
39,504,000  
26,121,000  
Lease incentives, net of current portion
792,000  
1,076,000  
Other liabilities
49,000  
436,000  
Commitments and contingencies (see Note 13)
xsi:nil  
xsi:nil  
Stockholders' equity:
 
 
Preferred stock, $0.001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2016 and December 31, 2015
xsi:nil  
 
Common stock, $0.001 par value; 200,000,000 shares authorized; 30,482,712 and 24,175,381 shares issued and outstanding at December 31, 2016
30,000  
24,000  
Additional paid-in capital
242,997,000  
195,800,000  
Accumulated deficit
(203,689,000) 
(148,885,000) 
Total stockholders' equity
39,338,000  
 
46,939,000  
 
Total liabilities and stockholders' equity
89,568,000  
 
86,825,000